For: | Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/1426.htm |
Number | Citing Articles |
1 |
Hasnain Imtiaz, Sharmin Afroz, Md Amir Hossain, Sm Faysal Bellah, Md Mostafizur Rahman, Md Shahin Kadir, Razia Sultana, Md Abdul Mazid, Md Mustafizur Rahman. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population. Tumor Biology 2019; 41(3): 101042831983083 doi: 10.1177/1010428319830837
|
2 |
Louise Baandrup, Louise T. Thomsen, Tina Bech Olesen, Klaus Kaae Andersen, Bodil Norrild, Susanne K. Kjaer. The prevalence of human papillomavirus in colorectal adenomas and adenocarcinomas: A systematic review and meta-analysis. European Journal of Cancer 2014; 50(8): 1446 doi: 10.1016/j.ejca.2014.01.019
|
3 |
Ten-i Godai, Tetsuji Suda, Nobuhiro Sugano, Kazuhito Tsuchida, Manabu Shiozawa, Hironobu Sekiguchi, Akiko Sekiyama, Mitsuyo Yoshihara, Shoichi Matsukuma, Yuji Sakuma, Eiju Tsuchiya, Yoichi Kameda, Makoto Akaike, Yohei Miyagi. Identification of colorectal cancer patients with tumors carrying the TP53mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-420
|
4 |
Natalia Volodko, Mohamed Salla, Bertus Eksteen, Richard N Fedorak, Hien Q Huynh, Shairaz Baksh. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. World Journal of Gastroenterology 2015; 21(36): 10358-10366 doi: 10.3748/wjg.v21.i36.10358
|
5 |
Xin Tian, Shundong Dai, Jing Sun, Shenyi Jiang, Youhong Jiang. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Oncotarget 2017; 8(1): 1156 doi: 10.18632/oncotarget.13589
|
6 |
Rami M. Elshazli, Eman A. Toraih, Abdelaziz Elgaml, Emad Kandil, Manal S. Fawzy. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 2020; 734: 144391 doi: 10.1016/j.gene.2020.144391
|
7 |
Santhi Latha Pandrangi, Sarangadhara Appala Raju Bagadi, Navin Kumar Sinha, Manoj Kumar, Rima Dada, Meena Lakhanpal, Abha Soni, Shreshtha Malvia, Sheeba Simon, Chintamani Chintamani, Ravindar Singh Mohil, Dinesh Bhatnagar, Sunita Saxena. Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis. Cancer Cell International 2014; 14(1) doi: 10.1186/1475-2867-14-14
|
8 |
Z Hosseinpour, Z Salehi, S Talesh Sasani, K Aminian. p53 and miR-34b/c genetic variation and their impact on ulcerative colitis susceptibility. British Journal of Biomedical Science 2018; 75(1): 46 doi: 10.1080/09674845.2017.1362729
|
9 |
Thaisa Pelizzer, Caroline Pieta Dias, Julia Poeta, Tânia Torriani, Cristian Roncada. Prevalência de câncer colorretal associado ao papilomavírus humano: uma revisão sistemática com metanálise. Revista Brasileira de Epidemiologia 2016; 19(4): 791 doi: 10.1590/1980-5497201600040009
|
10 |
Zhong-zheng Zhu, Bing Liu, Ai-zhong Wang, Hang-ruo Jia, Xia-xiang Jin, Xiang-lei He, Li-fang Hou, Guan-shan Zhu. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression. Journal of Zhejiang University SCIENCE B 2008; 9(11): 847 doi: 10.1631/jzus.B0820100
|
11 |
V. Polakova, B. Pardini, A. Naccarati, S. Landi, J. Slyskova, J. Novotny, L. Vodickova, J. L. Bermejo, M. Hanova, Z. Smerhovsky, E. Tulupova, R. Kumar, K. Hemminki, P. Vodicka. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Human Mutation 2009; 30(4): 661 doi: 10.1002/humu.20931
|
12 |
Carmen Ruth Manzione, Sidney Roberto Nadal. Papilomavírus humano e sua associação com o carcinoma colorretal. Revista Brasileira de Coloproctologia 2010; 30(4): 462 doi: 10.1590/S0101-98802010000400013
|
13 |
Rym Abderrahmane, Lotfi Louhibi, Fatima Zohra Moghtit, Amina Boubekeur, Khedidja Benseddik, Abdellah Boudjema, Fouzia Benrrahal, Meriem Aberkane, Mostefa Fodil, Nadhira Saidi-Mehtar. TP53 Arg 72Pro and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: A West Algerian Population Study. Pathology & Oncology Research 2015; 21(3): 629 doi: 10.1007/s12253-014-9867-6
|
14 |
Sanzana Fareen Rivu, Mohd Nazmul Hasan Apu, Samia Shabnaz, Noor Ahmed Nahid, Md. Reazul Islam, Mir Md. Abdullah Al-Mamun, Zabun Nahar, Sikder Nahidul Islam Rabbi, Maizbha Uddin Ahmed, Mohammad Safiqul Islam, Abul Hasnat. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population. Cancer Epidemiology 2017; 49: 46 doi: 10.1016/j.canep.2017.05.005
|
15 |
Barbara Fellerhoff, Songhai Gu, Barbara Laumbacher, Andreas G. Nerlich, Elisabeth H. Weiss, Jürgen Glas, Reinhard Kopp, Judith P. Johnson, Rudolf Wank. The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer. Cancer Research 2011; 71(23): 7145 doi: 10.1158/0008-5472.CAN-10-1883
|
16 |
Hye-Rim Song, Sun-Seog Kweon, Hee Nam Kim, Jin-Mei Piao, Woo-Jun Yun, Jin-Su Choi, Jun-Eul Hwang, Ju-Young Yoon, Hyeong-Rok Kim, Young-Kyu Park, Soo-Hyun Kim, Yoo-Duk Choi, Min-Ho Shin. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer 2011; 14(3): 242 doi: 10.1007/s10120-011-0034-4
|
17 |
Helena S Thurow, Ricardo Haack, Fernando P Hartwig, Isabel O de Oliveira, Odir A Dellagostin, Denise P Gigante, Bernardo L Horta, Tiago Collares, Fabiana K Seixas. TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. Journal of Biosciences 2011; 36(5): 823 doi: 10.1007/s12038-011-9147-5
|
18 |
Ilaria Bellini, Letizia Pitto, Maria G. Marini, Loredana Porcu, Paolo Moi, Sonia Garritano, Laura Boldrini, Giuseppe Rainaldi, Gabriella Fontanini, Massimo Chiarugi, Roberto Barale, Federica Gemignani, Stefano Landi. ΔN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region. Human Mutation 2010; 31(4): 456 doi: 10.1002/humu.21214
|
19 |
R. TACHEZY, T. JIRASEK, M. SALAKOVA, V. LUDVIKOVA, M. KUBECOVA, L. HORAK, V. MANDYS, E. HAMSIKOVA. Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS 2007; 115(3): 195 doi: 10.1111/j.1600-0463.2007.apm_526.x
|
20 |
Ayse Engin, Bensu Karahalil, Ali Karakaya, Atilla Engin. Association Between XRCC1 ARG399GLN and P53 ARG72PRO Polymorphisms and the Risk of Gastric and Colorectal Cancer in Turkish Population. Archives of Industrial Hygiene and Toxicology 2011; 62(3): 207 doi: 10.2478/10004-1254-62-2011-2098
|
21 |
Helena S. Thurow, Fernando P. Hartwig, Clarice S. Alho, Deborah S. B. S. Silva, Rafael Roesler, Ana Lucia Abujamra, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Bernardo L. Horta, Odir A. Dellagostin, Tiago Collares, Fabiana K. Seixas. Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs. Molecular Biology Reports 2013; 40(8): 4929 doi: 10.1007/s11033-013-2593-4
|
22 |
A. M. Joshi, S. Budhathoki, K. Ohnaka, R. Mibu, M. Tanaka, Y. Kakeji, Y. Maehara, T. Okamura, K. Ikejiri, K. Futami, T. Maekawa, Y. Yasunami. TP53 R72P and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: The Fukuoka Colorectal Cancer Study. Japanese Journal of Clinical Oncology 2011; 41(2): 232 doi: 10.1093/jjco/hyq200
|
23 |
Rui Liu, Li-Ling Hu, Ao Sun, Ya-Jing Cao, Tao Tang, Xi-Peng Zhang, Qing-Huai Zhang. mRNA Expression of IGF-1 and IGF-1R in Patients with Colorectal Adenocarcinoma and Type 2 Diabetes. Archives of Medical Research 2014; 45(4): 318 doi: 10.1016/j.arcmed.2014.04.003
|
24 |
A.S. Sameer, Z.A. Shah, N. Syeed, M.Z. Banday, S.M. Bashir, B.A. Bhat, M.A. Siddiqi. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genetics and Molecular Research 2010; 9(2): 651 doi: 10.4238/vol9-2gmr751
|
25 |
A. Naccarati, V. Polakova, B. Pardini, L. Vodickova, K. Hemminki, R. Kumar, P. Vodicka. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis 2012; 27(2): 211 doi: 10.1093/mutage/ger067
|
26 |
Andrés López-Cortés, Santiago Guerrero, María Redal, Angel Alvarado, Luis Quiñones. State of Art of Cancer Pharmacogenomics in Latin American Populations. International Journal of Molecular Sciences 2017; 18(6): 639 doi: 10.3390/ijms18060639
|
27 |
Rongxin Chen, Shu Liu, Huijing Ye, Jiali Li, Yi Du, Lingyan Chen, Xiaoman Liu, Yungang Ding, Qian Li, Yuxiang Mao, Siming Ai, Ping Zhang, Wenfang Ma, Huasheng Yang. Association of p53 rs1042522, MDM2 rs2279744 and p21 rs1801270 polymorphisms with retinoblastoma risk and invasion in a Chinese population. Scientific Reports 2015; 5(1) doi: 10.1038/srep13300
|
28 |
N.-P. Tang, Y.-M. Wu, B. Wang, J. Ma. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. European Journal of Surgical Oncology (EJSO) 2010; 36(5): 431 doi: 10.1016/j.ejso.2010.03.010
|
29 |
Gopi Krishna Singamsetty, Sravanthi Malempati, Srichandana Bhogadhi, Ravinder Kondreddy, Suresh Govatati, Naveen Kumar Tangudu, Sowdamani Govatati, Anil Kumar kuraganti, Manjula Bhanoori, Kondaiah Kassetty. TP53 alterations and colorectal cancer predisposition in south Indian population: A case-control study. Tumor Biology 2014; 35(3): 2303 doi: 10.1007/s13277-013-1305-y
|
30 |
Laura Lorenzon, Mario Ferri, Emanuela Pilozzi, Maria Rosaria Torrisi, Vincenzo Ziparo, Deborah French. Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature. International Journal of Colorectal Disease 2011; 26(2): 135 doi: 10.1007/s00384-010-1049-8
|
31 |
Silvia Mahmood, Monika Sivoňová, Tatiana Matáková, Dusan Dobrota, Ladislava Wsólová, Anton Dzian, Dusan Mištuna. Association of EGF and p53 gene polymorphisms and colorectal cancer risk in the Slovak population. Open Medicine 2014; 9(3): 405 doi: 10.2478/s11536-013-0300-4
|
32 |
Issa J. Dahabreh, Helena Linardou, Peggy Bouzika, Vasileia Varvarigou, Samuel Murray.
TP53 Arg72Pro Polymorphism and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis. Cancer Epidemiology, Biomarkers & Prevention 2010; 19(7): 1840 doi: 10.1158/1055-9965.EPI-10-0156
|
33 |
Fatih Eren, Mustafa Akkiprik, Özlen Atuğ, Özgür Sönmez, Gülgün Tahan, Filiz Özdemir, Hülya Över Hamzaoğlu, Çiğdem Ataizi Çelikel, Neşe İmeryüz, Erol Avşar, Ayşe Özer. R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History. Pathology & Oncology Research 2010; 16(4): 563 doi: 10.1007/s12253-010-9255-9
|
34 |
Samia Shabnaz, Maizbha Uddin Ahmed, Md. Siddiqul Islam, Md. Reazul Islam, Mir Md. Abdullah Al-Mamun, Mohammad Safiqul Islam, Abul Hasnat. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women. Tumor Biology 2016; 37(6): 7229 doi: 10.1007/s13277-015-4612-7
|
35 |
Marzeah Zaker Hosseini, Sirous Naeimi, Maryam Moradinasab, Sakeneh Taherkhani, Fatemeh Farshadpour, Akram Ansarifar, Reza Taherkhani. Codon 72 Polymorphism of TP53 Gene in Cervical Biopsies with Abnormal Histology in Bushehr Province. Iranian South Medical Journal 2018; 21(1): 19 doi: 10.29252/ismj.21.1.19
|
36 |
Liu Liu, Kai Wang, Zheng-Ming Zhu, Jiang-Hua Shao. Associations Between P53 Arg72Pro and Development of Digestive Tract Cancers: A Meta-analysis. Archives of Medical Research 2011; 42(1): 60 doi: 10.1016/j.arcmed.2011.01.008
|
37 |
Jing-Jun Wang, Yuan Zheng, Liang Sun, Li Wang, Peng-Bo Yu, Jian-Hua Dong, Lei Zhang, Jing Xu, Wei Shi, Yu-Chun Ren. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis. Molecular Biology Reports 2011; 38(8): 4847 doi: 10.1007/s11033-010-0619-8
|
38 |
Ikhlas A Sindi, Ahmed O Babalghith, Mohammed T Tayeb, Ahmad H Mufti, Hind Naffadi, Samar N Ekram, Ezzeldin N Elhawary, Munaifah Alanezi, Nasser A Elhawary. Risk of Colorectal Carcinoma May Predispose to the Genetic Variants of the GST, CYP450, and TP53 Genes Among Nonsmokers in the Saudi Community. International Journal of General Medicine 2021; : 1311 doi: 10.2147/IJGM.S294802
|
39 |
E. Mammano, C. Belluco, M. Bonafé, F. Olivieri, E. Mugianesi, C. Barbi, M. Mishto, M. Cosci, C. Franceschi, M. Lise, D. Nitti. Association of p53 polymorphisms and colorectal cancer: Modulation of risk and progression. European Journal of Surgical Oncology (EJSO) 2009; 35(4): 415 doi: 10.1016/j.ejso.2008.03.003
|
40 |
Abram Bunya Kamiza, Ling-Ling Hsieh, Reiping Tang, Huei-Tzu Chien, Chih-Hsiung Lai, Li-Ling Chiu, Tsai-Ping Lo, Kuan-Yi Hung, Jeng-Fu You, Wen-Chang Wang, Chao A. Hsiung, Chih-Ching Yeh, Kanaga Sabapathy. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study. PLOS ONE 2016; 11(12): e0167354 doi: 10.1371/journal.pone.0167354
|
41 |
LIGIA PETROLINI DE OLIVEIRA, IGNACIO LÓPEZ, ERIKA MARIA MONTEIRO DOS SANTOS, PAULA TUCCI, MÓNICA MARÍN, FERNANDO AUGUSTO SOARES, BENEDITO MAURO ROSSI, RENATA DE ALMEIDA COUDRY. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis. Oncology Reports 2014; 31(3): 1396 doi: 10.3892/or.2013.2940
|
42 |
Zahra Montazeri, Evropi Theodoratou, Christine Nyiraneza, Maria Timofeeva, Wanjing Chen, Victoria Svinti, Shanya Sivakumaran, Gillian Gresham, Laura Cubitt, Luis Carvajal-Carmona, Monica M Bertagnolli, Ann G Zauber, Ian Tomlinson, Susan M Farrington, Malcolm G Dunlop, Harry Campbell, Julian Little. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. International Journal of Epidemiology 2016; 45(1): 186 doi: 10.1093/ije/dyv185
|
43 |
Zhong-Zheng Zhu, Ai-Zhong Wang, Hang-Ruo Jia, Xia-Xiang Jin, Xiang-Lei He, Li-Fang Hou, Guanshan Zhu. Association of the TP53 Codon 72 Polymorphism with Colorectal Cancer in a Chinese Population. Japanese Journal of Clinical Oncology 2007; 37(5): 385 doi: 10.1093/jjco/hym034
|
44 |
Toru Hiyama, Masaharu Yoshihara, Shinji Tanaka, Kazuaki Chayama. Genetic polymorphisms and esophageal cancer risk. International Journal of Cancer 2007; 121(8): 1643 doi: 10.1002/ijc.23044
|
45 |
Ramesh T. Gunaratna, Andres Santos, Linjie Luo, Chandandeep Nagi, Isabel Lambertz, Madison Spier, Claudio J. Conti, Robin S. Fuchs-Young. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model. Oncogene 2019; 38(18): 3535 doi: 10.1038/s41388-018-0630-4
|